| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/16/2004 | US6706471 Detection of nucleic acid sequences by invader-directed cleavage |
| 03/16/2004 | CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same |
| 03/12/2004 | CA2402963A1 Receptor |
| 03/11/2004 | WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 03/11/2004 | WO2004020671A1 Primer and probe for detecting vibrio vulnificus and detection method using the same |
| 03/11/2004 | WO2004020653A2 Analytical method for the determination of infant formula protein digestibility in vitro |
| 03/11/2004 | WO2004020642A2 Stress tolerance and delayed senescence in plants |
| 03/11/2004 | WO2004020638A1 Process for producing glucose dehydrogenases |
| 03/11/2004 | WO2004020637A1 Flavonoid 3',5'hydroxylase gene sequences and uses therefor |
| 03/11/2004 | WO2004020635A1 Bacteriophages and remedies for bacterial infection |
| 03/11/2004 | WO2004020628A1 Method for genetically engineering plant-derived nucleic acid sequences comprising gene shuffling and selective mutagenesis |
| 03/11/2004 | WO2004020627A2 Improved dna and proteins |
| 03/11/2004 | WO2004020621A1 Thermostable ribonuclease h |
| 03/11/2004 | WO2004020620A1 Regulation of human esterase |
| 03/11/2004 | WO2004020619A1 Modified phospholipase c-gamma-2, expression products, and non-human animal models comprising said genes, and therapeutic uses |
| 03/11/2004 | WO2004020618A1 Streptococccus suis surface proteins, ornithine carbamolytransferase and arginine deiminase, expressed under stress conditions |
| 03/11/2004 | WO2004020612A1 Methods for producing mammalian trypsins |
| 03/11/2004 | WO2004020587A2 Carboxypeptidase b related polypeptides and methods of use |
| 03/11/2004 | WO2004020467A2 Novel mucin binding polypeptides derived from lactobacillus johnsonii |
| 03/11/2004 | WO2004020451A1 Group b streptococcal phage lysin |
| 03/11/2004 | WO2004019983A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004009820A8 Method for obtaining the pathogenic resistance in plants |
| 03/11/2004 | WO2003097793A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/11/2004 | WO2003091396A3 Polypeptides and biosynthetic pathways |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003077642A3 Population of transgenic plants, biological material derived therefrom, corresponding plasmid collection and population of transformed host organisms, use thereof and methods for producing the same |
| 03/11/2004 | WO2003072790A3 Production of dadzein in transgenic plants |
| 03/11/2004 | WO2003072767A3 Regulation of human lipase |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003062410A3 Torero protein |
| 03/11/2004 | WO2003057867A3 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003045985A3 Purified polypeptides involved in carbohydrate and coenzyme metabolism |
| 03/11/2004 | WO2003035878A3 Lipase variants |
| 03/11/2004 | WO2003035826A3 Genetic screening methods |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003016498A3 Molecular interaction sites of rnase p rna and methods of modulating the same |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2002099063A8 Alteration of embryo/endosperm size during seed development |
| 03/11/2004 | WO2002097055A3 Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase a2 |
| 03/11/2004 | WO2002095068A3 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 03/11/2004 | WO2002095004A3 Foamy virus mutant reverse transcriptase |
| 03/11/2004 | WO2002087624A3 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002077191A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/11/2004 | WO2002062135A8 Scce modified transgenic mammals and their use as models of human disease |
| 03/11/2004 | US20040049813 Provides an alternative to the production of more expensive oils and to the chemical modification of oil to provide specific functional qualities and health attributes; useful in the manufacture of margarine and spread products |
| 03/11/2004 | US20040049812 Methods of achieving expression in plants without damaging the plant cell, the protein can be recovered without contamination by other proteases, and can be expressed at levels for commercial production of the enzyme |
| 03/11/2004 | US20040049811 Used in transgenic plants to promote high levels of expression of foreign and endogenous genes in developing seeds to affect seed lipid metabolism, protein or carbohydrate composition and accumulation, or seed development |
| 03/11/2004 | US20040049810 Maize gene dull1 (du1) is a determinant of the structure of endosperm starch |
| 03/11/2004 | US20040049809 Pear genes codifying for beta-galactosidase,pectin methylesterse, polygalacturonase, expansins and their use |
| 03/11/2004 | US20040049808 Methods of imparting resistance to insects and fungi, regulating the fiber cellulose content |
| 03/11/2004 | US20040049807 A pathway for defense responses in plants, and genes involved in that pathway |
| 03/11/2004 | US20040049806 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme |
| 03/11/2004 | US20040049805 Plant promoters with an expression specificity for plant seeds; used as food, feed or seed, pharmaceuticals, fine chemicals or as industrial feedstock |
| 03/11/2004 | US20040049803 Metallothionein (MTI) and glutamine synthatase (GS) promoters capable of promoting the senescence-associated expression of nucleic acid coding sequences |
| 03/11/2004 | US20040049802 Method for modifying lignin composition and increasing in vivo digestibility of forages |
| 03/11/2004 | US20040049352 Designing modulators for glycosyltransferases |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049042 Preparing steriods, such as 3-oxo-4-azasteroids, having 5a-reductase activity by hydrogenation of the corresponding steroid alkene in the presence of ammonium acetate, ammonium formate, and/or ammonium propionate and a catalyst. |
| 03/11/2004 | US20040049025 Recombinant viral nucleic acids |
| 03/11/2004 | US20040049015 Antibodies specific to human prostacyclin synthase |
| 03/11/2004 | US20040048826 Oligonucleotides containing 2'-0-modified purines |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048815 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/11/2004 | US20040048803 Treatment of thrombosis by administering a CD154 inhibitor, especially a metalloproteinase inhibitor. |
| 03/11/2004 | US20040048382 Nucleic acid fragments encoding proteins involved in hemicellulose production in plants and seeds |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048351 Alpha-amylase mutants |
| 03/11/2004 | US20040048350 Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof |
| 03/11/2004 | US20040048349 Human orthologues of Wart |
| 03/11/2004 | US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 03/11/2004 | US20040048345 Process for producing trans-4-hydroxy-L-proline |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048309 DNA from thermophilic bacterium; chromosomal replicases |
| 03/11/2004 | US20040048308 Thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 03/11/2004 | US20040048305 For diagnosis of cancer, immunological disorders, viral disorders, and apoptotic disorders; kits; drug screening |
| 03/11/2004 | US20040048303 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/11/2004 | US20040048302 Used for diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides |
| 03/11/2004 | US20040048290 Aminoacyl trna synthetases |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048269 Used in the diagnosis, treatment, and prevention of cancer, neurological disorders, autoimmune/inflammatory disorders, gastrointestinal disorders, and cardiovascular disorders |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048255 Peptide of given amino acid sequence; identifying molecules that bind to and modulate the protease |
| 03/11/2004 | US20040048249 Novel nucleic acids and secreted polypeptides |
| 03/11/2004 | US20040048247 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047954 Analytical method for the determination of infant formula protein digestibility in vitro |
| 03/11/2004 | US20040047923 Infiltrating with a buffer solution; vacuum environment; centrifuging and concentrating |
| 03/11/2004 | US20040047854 New disintegrin polypeptide, methods of making such polypeptides, and methods of using them to treat disintegrin-associated disorders and conditions and to identify agents that modulate Metalloproteinase-Disintegrin |
| 03/11/2004 | US20040047853 Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |